A phase II randomized open-label trial of biweekly pemetrexed plus gemcitabine versus pemetrexed or pemetrexed plus carboplatin in relapsed non small cell lung cancer after neoadjuvant or adjuvant chemotherapy
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2010
At a glance
- Drugs Carboplatin; Gemcitabine; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 09 Aug 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 23 Oct 2009 Status changed from not stated to active, no longer recruiting.
- 05 Jul 2006 New trial record.